During the past decade, Children's Hospital of Philadelphia Onc. Dept conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Children's Hospital of Philadelphia Onc. Dept" are "Chronic Iron Overload Due to Transfusion-dependant Anemias" (1 trials) and "Transfusion-dependent Anemia" (1 trials). Many other conditions were trialed in "Children's Hospital of Philadelphia Onc. Dept" in a lesser frequency.

Most popular intervention types in "Children's Hospital of Philadelphia Onc. Dept" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Defearisox film-coated tablet" (1 trials), "Deferasirox DT formulation" (1 trials), "Deferasirox dispersible tablet" (1 trials) and "Deferasirox granule formulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Children's Hospital of Philadelphia Onc. Dept" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Children's Hospital of Philadelphia Onc. Dept". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Children's Hospital of Philadelphia Onc. Dept, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Children's Hospital of Philadelphia Onc. Dept, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".